about
Rheumatic disease and the Australian aborigineHLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps.Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.Bilateral macular thickening in mild unilateral anterior uveitis: is HLA-B27 involved?Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelaeHLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population.Epidemiology of spondyloarthritis.HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis.Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza ATime trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study.Campylobacter reactive arthritis: a systematic reviewPrevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity.Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.Gut Microbiota Perturbations in Reactive Arthritis and Post-Infectious Spondyloarthritis.MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.Interethnic Variations and Clinical Features of Spondyloarthropathies in a Middle Eastern Country.Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.A case of ankylosing spondylitis with concurrent Takayasu arteritis.
P2860
Q24675107-A7012956-4AED-442A-8B75-F0024D9E32BAQ32173857-8C987CCB-0791-4A32-9833-4184E6BAE9C7Q33584246-795A8EE2-3F9C-40A7-BE69-CF2AB3B0D7AFQ34354352-D134F0A9-6D7E-4AC1-887B-19B3A9F73ED0Q35229830-C375E6E6-40FC-4082-A5CC-A82264EE7C3EQ35313989-E178341C-2C47-43C0-BE7C-54F8E986D06CQ35750729-0662D67F-CF07-45BD-A247-BF354C80EC98Q35762754-D86823D2-9D61-4D1F-83E8-1D5B00516B54Q35979077-3BC6BA72-AD0D-497B-85C5-9AF0AB54C710Q35997346-83D0D4ED-313F-487F-9AF7-407883B825A9Q36759683-3F4F38FC-6601-489C-863E-EC0D1D74CD2DQ37690183-5D4B7785-3DF8-49A4-AA3A-D9D688446ECBQ43053796-81B4DD01-01A6-401A-8F90-47C325261364Q46274080-75F79276-0B5B-4642-9F29-5FED5DE4A6D8Q49677530-E55E82A2-3513-415C-9586-FB1DFB6CD840Q49874554-068E24C5-BE17-462E-9A00-6F0B0045F8B3Q52727983-E71F215A-8965-4F73-9F55-370B1820DB10Q55443702-A7564B6F-BC43-4EA3-B42C-0CCB0772B083
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
HLA-B27 and its subtypes in world populations.
@en
HLA-B27 and its subtypes in world populations.
@nl
type
label
HLA-B27 and its subtypes in world populations.
@en
HLA-B27 and its subtypes in world populations.
@nl
prefLabel
HLA-B27 and its subtypes in world populations.
@en
HLA-B27 and its subtypes in world populations.
@nl
P1476
HLA-B27 and its subtypes in world populations.
@en
P2093
P304
P577
1995-07-01T00:00:00Z